Literature DB >> 2062846

Hypoxia-inducible nuclear factors bind to an enhancer element located 3' to the human erythropoietin gene.

G L Semenza1, M K Nejfelt, S M Chi, S E Antonarakis.   

Abstract

Human erythropoietin gene expression in liver and kidney is inducible by anemia or hypoxia. DNase I-hypersensitive sites were identified 3' to the human erythropoietin gene in liver nuclei. A 256-base-pair region of 3' flanking sequence was shown by DNase I protection and electrophoretic mobility-shift assays to bind four or more different nuclear factors, at least two of which are induced by anemia in both liver and kidney, and the region functioned as a hypoxia-inducible enhancer in transient expression assays. These results provide insight into the molecular basis for the regulation of gene expression by a fundamental physiologic stimulus, hypoxia.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2062846      PMCID: PMC51941          DOI: 10.1073/pnas.88.13.5680

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Studies on erythropoiesis. III. Factors controlling erythropoietin production.

Authors:  W FRIED; E GOLDWASSER; L O JACOBSON; L F PLZAK
Journal:  Proc Soc Exp Biol Med       Date:  1957-01

2.  The regulated expression of erythropoietin by two human hepatoma cell lines.

Authors:  M A Goldberg; G A Glass; J M Cunningham; H F Bunn
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

3.  Homologous recognition of a promoter domain common to the MSV LTR and the HSV tk gene.

Authors:  B J Graves; P F Johnson; S L McKnight
Journal:  Cell       Date:  1986-02-28       Impact factor: 41.582

4.  Localization of erythropoietin synthesizing cells in murine kidneys by in situ hybridization.

Authors:  S T Koury; M C Bondurant; M J Koury
Journal:  Blood       Date:  1988-02       Impact factor: 22.113

5.  Cloning and expression of the human erythropoietin gene.

Authors:  F K Lin; S Suggs; C H Lin; J K Browne; R Smalling; J C Egrie; K K Chen; G M Fox; F Martin; Z Stabinsky
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

6.  Anemia induces accumulation of erythropoietin mRNA in the kidney and liver.

Authors:  M C Bondurant; M J Koury
Journal:  Mol Cell Biol       Date:  1986-07       Impact factor: 4.272

7.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

8.  Rearrangement and expression of erythropoietin genes in transformed mouse cells.

Authors:  J McDonald; N Beru; E Goldwasser
Journal:  Mol Cell Biol       Date:  1987-01       Impact factor: 4.272

9.  Expression of the erythropoietin gene.

Authors:  N Beru; J McDonald; C Lacombe; E Goldwasser
Journal:  Mol Cell Biol       Date:  1986-07       Impact factor: 4.272

10.  Regulation of glycolytic enzyme RNA transcriptional rates by oxygen availability in skeletal muscle cells.

Authors:  K A Webster
Journal:  Mol Cell Biochem       Date:  1987-09       Impact factor: 3.396

View more
  242 in total

Review 1.  Antagonising angiogenesis in rheumatoid arthritis.

Authors:  P E Brenchley
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

Review 2.  Angiogenesis in inflammatory joint disease: a target for therapeutic intervention.

Authors:  P E Brenchley
Journal:  Clin Exp Immunol       Date:  2000-09       Impact factor: 4.330

3.  Regulation of endothelin-1 gene expression in human microvascular endothelial cells by hypoxia and cobalt: role of hypoxia responsive element.

Authors:  A Minchenko; J Caro
Journal:  Mol Cell Biochem       Date:  2000-05       Impact factor: 3.396

4.  Killing of brain tumor cells by hypoxia-responsive element mediated expression of BAX.

Authors:  H Ruan; J Wang; L Hu; C S Lin; K R Lamborn; D F Deen
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

5.  A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation.

Authors:  G L Semenza; G L Wang
Journal:  Mol Cell Biol       Date:  1992-12       Impact factor: 4.272

6.  Chimeric p53 as an alternative therapy for hypoxic tumors.

Authors:  Jun-Ho Lee; Hua Lu
Journal:  Cancer Biol Ther       Date:  2011-01-01       Impact factor: 4.742

7.  Factors predisposing metastatic tumor antigen 1 overexpression in hepatitis B virus associated hepatocellular carcinoma.

Authors:  Young-Joo Jin; Young-Hwa Chung; Jeong A Kim; Won Hyung Park; Danbi Lee; Dong Dae Seo; Soo Hyung Ryu; Myoung Kuk Jang; Eunsil Yu; Young Joo Lee
Journal:  Dig Dis Sci       Date:  2012-07-10       Impact factor: 3.199

8.  An HRE-Binding Py-Im Polyamide Impairs Hypoxic Signaling in Tumors.

Authors:  Jerzy O Szablowski; Jevgenij A Raskatov; Peter B Dervan
Journal:  Mol Cancer Ther       Date:  2015-12-30       Impact factor: 6.261

Review 9.  Imaging tumor hypoxia to advance radiation oncology.

Authors:  Chen-Ting Lee; Mary-Keara Boss; Mark W Dewhirst
Journal:  Antioxid Redox Signal       Date:  2014-03-24       Impact factor: 8.401

10.  Gene therapy for long-term expression of erythropoietin in rats.

Authors:  W R Osborne; N Ramesh; S Lau; M M Clowes; D C Dale; A W Clowes
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.